# Proparacaine and Mydriatic Eye Drops

> **NCT01266824** · NA · TERMINATED · sponsor: **Children's Hospital of Philadelphia** · enrollment: 5 (actual)

## Conditions studied

- Pain
- Retinopathy of Prematurity

## Interventions

- **DRUG:** Proparacaine Hydrochloride Ophthalmic Solution

## Key facts

- **NCT ID:** NCT01266824
- **Lead sponsor:** Children's Hospital of Philadelphia
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-12
- **Primary completion:** 2011-08
- **Final completion:** 2011-08
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** Recruitment for the study has been terminated due to poor enrollment
- **Last updated:** 2013-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01266824

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01266824, "Proparacaine and Mydriatic Eye Drops". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT01266824. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*